SCHEMBL7730641

SCHEMBL7730641

Cc1ccc(Cl)c(OC2CCN(C(=O)[C@@H]3C[C@@H](N(C(=O)CN)C(=O)OC(C)(C)C)CN3C(=O)OC(C)(C)C)CC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 1/20 0.39
MCHR1 Q99705 1/20 0.39
PDE4B Q07343 3/20 0.35
PDE4D Q08499 3/20 0.35
PDE4A P27815 2/20 0.35
PDE4C Q08493 2/20 0.35
GPR119 Q8TDV5 2/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
PREP P48147 2/20 0.34
GPR6 P46095 1/20 0.34
TOP2A P11388 1/20 0.34
LMNA P02545 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TGM2 P21980 1/20 0.34
KDM1A O60341 1/20 0.33
CACNB4 O00305 1/20 0.33
CACNA1A O00555 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7722244 0.85 GPR119 (0.36) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL7722094 0.85 GPR119 (0.36) GPR119CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL7722004 0.79 TGM2 (0.40) POLBLMNATGM2
SCHEMBL7730976 0.78 MCL1 (0.44) GPR119
SCHEMBL7730697 0.78 SMN1; SMN2 (0.44) GPR119LMNANPSR1TGM2
SCHEMBL7730651 0.77 NPBWR1 (0.41) NPBWR1MCHR1PDE4BPDE4DPDE4A
SCHEMBL7730638 0.77 NPBWR1 (0.41) NPBWR1MCHR1PDE4BPDE4DPDE4A
SCHEMBL7730647 0.77 NPBWR1 (0.41) NPBWR1MCHR1PDE4BPDE4DPDE4A
SCHEMBL7728745 0.77 MAPT (0.44) CYP1A2POLBCYP3A4CYP2C19LMNA
SCHEMBL7727287 0.76 NPBWR1 (0.57) NPBWR1MCHR1PDE4BPDE4DPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed